Egrifta (EMD Serono, Inc.)
Welcome to the PulseAid listing for the Egrifta drug offered from EMD Serono, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | EMD Serono, Inc. |
| NON-PROPRIETARY NAME: | tesamorelin |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-09-05 |
| END MARKETING DATE: | 0000-00-00 |
Egrifta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Egrifta from EMD Serono, Inc. |
| LABELER NAME: | EMD Serono, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2012-09-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44087-2011_9952905b-10a4-45d6-8eec-c4104aca002f |
| PRODUCT NDC: | 44087-2011 |
| APPLICATION NUMBER: | NDA022505 |